Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.08 EUR
−15.12 M EUR
8.29 M EUR
11.48 M
About Aspira Women's Health Inc.
Sector
Industry
CEO
Nicole Sandford
Website
Headquarters
Austin
Founded
1993
FIGI
BBG000Q9QHR6
Aspira Women's Health, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CUL is 0.71 EUR — it has decreased by −25.18% in the past 24 hours. Watch ASPIRA WOMEN'S HEALTH INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange ASPIRA WOMEN'S HEALTH INC stocks are traded under the ticker CUL.
CUL stock has risen by 4.00% compared to the previous week, the month change is a −35.40% fall, over the last year ASPIRA WOMEN'S HEALTH INC has showed a −76.18% decrease.
We've gathered analysts' opinions on ASPIRA WOMEN'S HEALTH INC future price: according to them, CUL price has a max estimate of 5.10 EUR and a min estimate of 2.78 EUR. Watch CUL chart and read a more detailed ASPIRA WOMEN'S HEALTH INC stock forecast: see what analysts think of ASPIRA WOMEN'S HEALTH INC and suggest that you do with its stocks.
CUL stock is 35.58% volatile and has beta coefficient of −0.85. Track ASPIRA WOMEN'S HEALTH INC stock price on the chart and check out the list of the most volatile stocks — is ASPIRA WOMEN'S HEALTH INC there?
Today ASPIRA WOMEN'S HEALTH INC has the market capitalization of 11.91 M, it has increased by 4.17% over the last week.
Yes, you can track ASPIRA WOMEN'S HEALTH INC financials in yearly and quarterly reports right on TradingView.
ASPIRA WOMEN'S HEALTH INC is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
CUL earnings for the last quarter are −0.25 EUR per share, whereas the estimation was −0.23 EUR resulting in a −9.24% surprise. The estimated earnings for the next quarter are −0.22 EUR per share. See more details about ASPIRA WOMEN'S HEALTH INC earnings.
ASPIRA WOMEN'S HEALTH INC revenue for the last quarter amounts to 2.07 M EUR, despite the estimated figure of 2.50 M EUR. In the next quarter, revenue is expected to reach 2.92 M EUR.
CUL net income for the last quarter is −3.19 M EUR, while the quarter before that showed −3.30 M EUR of net income which accounts for 3.33% change. Track more ASPIRA WOMEN'S HEALTH INC financial stats to get the full picture.
No, CUL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 26, 2024, the company has 64.00 employees. See our rating of the largest employees — is ASPIRA WOMEN'S HEALTH INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ASPIRA WOMEN'S HEALTH INC EBITDA is −15.15 M EUR, and current EBITDA margin is −203.77%. See more stats in ASPIRA WOMEN'S HEALTH INC financial statements.
Like other stocks, CUL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ASPIRA WOMEN'S HEALTH INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ASPIRA WOMEN'S HEALTH INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ASPIRA WOMEN'S HEALTH INC stock shows the sell signal. See more of ASPIRA WOMEN'S HEALTH INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.